Binney Street Capital
Boston, United States3
59M
2
1.00
0.33
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 1.00
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Life Science (2)
- Therapeutics (2)
- Biopharma (1)
- Investments by region
- United States (3)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| NextPoint Therapeutics | 14 Feb 2024 | Biotechnology, Health Care, Life Science, Therapeutics | Early Stage Venture | 42M | United States, Massachusetts, Cambridge |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| ChipAgents | Oct 21, 2025 | AI, Chip Design and Verification | - | 21000000 USD | Santa Barbara, California |
| nEye Systems | Oct 4, 2025 | Data Centers, Hyperscale Data Centers, Optical Switch, Silicon Photonics | - | 58000000 USD | Emeryville, California |
| 9fin | Dec 2, 2024 | AI-powered analytics, AI-powered analytics platform, AI tools, Analytics Platform, Credit information intelligence, debt capital markets, Debt capital markets, Debt Capital Markets, Generative AI | Growth stage | 50000000 USD |  London, |
| iotaSciences | Jul 31, 2024 | Cell and Gene Therapy (CGT), Single-cell biology handling solutions | - | - | Oxford, England |
| GlobalComix | Jul 21, 2023 | Digital Entertainment, Immersive Reading Experience, Monetization Tools | Early stage | 6500000 USD | Pittsburgh, Pennsylvania |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.